Manufacturing

Articles

The new facility, which will be Evotec’s first in Europe, will aim to offer capacity, flexibility, and quality for biotherapeutic development and manufacturing while utilizing technology that employs small, automated, highly intensified, and continuous bioprocessing operations inside autonomous cleanrooms.

Evotec Launches Biomanufacturing Facility in France

Catalent’s new mammalian cell culture suites in Madison, Wis. use single-use bioreactor systems for CGMP clinical and commercial manufacturing.

Catalent Completes Expansion of its Biologics Drug Substance Facility in Wisconsin  

The China National Medical Products Administration has given the company the green light to begin manufacturing commercial supply of its approved anti-PD-1 antibody, tislelizumab, at its biologics facility in Guangzhou, China.

China Approves BeiGene for Commercial Manufacturing at its Biologics Facility

The 3M Polisher ST from 3M Health Care is a single-use anion exchange (AEX) chromatography solution intended to replace the reusable AEX polishing column for biologic drug manufacturing.

Chromatography Solution for Biologic Drugs

Integration of Brooks Life Sciences BioStore III automated storage and inventory monitoring solution with Cytiva’s Chronicle software will improve traceability, process control, and monitoring capabilities.

Cytiva Integrates Brooks Life Sciences Automated Cold Chain Storage Platform

Jennifer Markarian is a contributing editor for 

Collaboration between equipment suppliers and users is leading to innovation and optimization in biopharmaceutical manufacturing.

Equipment Suppliers and CDMOs Advance Process Development

Cytiva’s new facility in Shrewsbury, MA will make equipment such as single-use bioreactors. 

Cytiva Opens New Manufacturing Facility in Massachusetts

The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe. 

BD to Invest $1.2 Billion Over Four Years in Pre-Fillable Syringe Manufacturing Capacity 

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Pharmaceutical Technology spoke with Tania Pereira Chilima, Deputy CTO at Univercells Technologies about their technology and how it can be used in viral vector manufacturing, which is needed for production of some of the COVID-19 vaccine candidates. 

Intensifed Process Offers Cost-Effective Viral Vector Manufacturing

The new super plant, being built in Incheon, South Korea, will have a total biopharmaceutical manufacturing capacity of 256,000 L.

Manufacturing Equipment, Biologics